HomeStock ScreenerEIKO LifesciencesQuarterly Results

EIKO Lifesciences Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹2 Cr
QMar 2026
Quarterly Results

In Mar 2026, EIKO Lifesciences (EIKO) reported revenue ₹19 Cr and net profit ₹2 Cr — revenue +58.3% YoY. Also explore EIKO share price history to track price trends across different timeframes.

EIKO Quarterly Results — Revenue, Profit & EPS Highlights

EIKO Lifesciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Browse EIKO cash flow statement for revenue, profit, balance sheet and cash flow data.

  • Revenue of ₹19 Cr in Mar 2026 (+58.3% vs Sept 2025, +58.3% vs Mar 2025)
  • Net Profit of ₹2 Cr in Mar 2026 (+100.0% vs Sept 2025, +100.0% vs Mar 2025)
  • EBITDA of ₹2 Cr in Mar 2026 (+0.0% vs Sept 2025)
  • Operating Margin of 12.0% in Mar 2026 (-3.0pp vs Sept 2025)
  • Earnings Per Share of ₹0.93 in Mar 2026 (+19.2% vs Sept 2025)

EIKO Lifesciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EIKO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 19 12 12 11 12 58.3% 58.3%
Net Profit (₹ Cr) 2 1 1 1 1 - -
EBITDA (₹ Cr) 2 2 2 2 2 - -
EPS (₹) 0.93 0.78 0.80 0.66 0.88 - -
Operating Margin (%) 12.0% 15.0% 12.0% 14.0% 16.0% - -

EIKO Share Price Trend — 1-Year Movement Across Quarterly Results

EIKO Lifesciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit EIKO share price.

Profitability Ratios

Profit Margin 10.5%
EBITDA Margin 10.5%
Operating Margin 12.0%
ROE (Annual) 11.6%

Balance Sheet Highlights

Total Assets ₹89 Cr
Total Equity ₹69 Cr
Current Assets ₹47 Cr
Current Liabilities ₹4 Cr

Cash Flow Analysis

Operating Cash Flow ₹3 Cr
Investing Cash Flow ₹-11 Cr
Financing Cash Flow ₹7 Cr
Net Cash Flow ₹-2 Cr

Current Market Data

Current Price ₹48.93
Exchange BSE
Last Updated Jul 24, 2026

EIKO vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

EIKO Lifesciences latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026
₹163,719.34 Cr 1570.9 3,648 584 +1.2% +13.2% 16.0% 276.1
SRF
Mar 2026
₹81,872.54 Cr 2664.7 4,557 582 +28.0% +7.2% 12.8% 135.7
Coromandel Internat…
Mar 2026
₹60,014.83 Cr 1980.8 6,068 115 -37.9% +11.1% 1.9% 417.0
Linde
Mar 2026
₹59,771.45 Cr 6731.0 621 77 -4.5% +2.6% 12.4% 741.3
Fertilisers & Chemi…
Sept 2025
₹52,674.89 Cr 809.3 1,681 21 +48.8% - 1.2% 2529.1
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores